Abstract
ADAMTS12 belongs to the family of metalloproteinases that mediate a communication between specific cell types and play a key role in the regulation of normal tissue development, remodeling, and degradation. Members of this family have been implicated in neurodegenerative and neuroinflammatory, as well as in muscular-skeletal, cardiovascular, respiratory and renal diseases, and cancer. Several metalloproteinases have been associated with schizophrenia. In our previous study of the pedigree from a genetic isolate of Spanish origin in Puerto Rico, we identified a schizophrenia susceptibility locus on chromosome 5p13 containing ADAMTS12. This gene, therefore, is not only a functional but also a positional candidate gene for susceptibility to the disorder. In order to examine possible involvement of ADAMTS12 in schizophrenia, we performed mutation analysis of the coding, 5′- and 3′-untranslated, and putative promoter regions of the gene in affected members of the pedigree and identified 18 sequence variants segregated with schizophrenia. We then tested these variants in 135 unrelated Puerto Rican schizophrenia patients of Spanish origin and 203 controls and identified the intronic variant rs256792 (P = 0.0035; OR = 1.59; 95% CI = 1.16–2.17) and the two-SNP haplotype rs256603–rs256792 (P = 0.0023; OR = 1.62; 95% CI = 1.19–2.21) associated with the disorder. The association remained significant after correction for multiple testing. Our data support the hypothesis that genetic variations in ADAMTS12 influence the risk of schizophrenia.
Similar content being viewed by others
References
Agrawal, S. M., Lau, L., & Yong, V. W. (2008). MMP in the central nervous system: Where the good guys go bad. Seminars in Cell & Developmental Biology, 19, 42–51.
Allebeck, P. (1989). Schizophrenia: A life-shortening disease. Schizophrenia Bulletin, 15, 81–89.
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search tool. Journal of Molecular Biology, 215, 403–410.
Apte, S. S. (2004). A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: The ADAMTS family. International Journal of Biochemistry and Cell Biology, 36, 981–985.
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005). Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263–265.
Basile, D. P., Fredrich, K., Chelladurai, B., Leonard, E. C., & Parrish, A. R. (2008). Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. American Journal of Physiology—Renal Physiology, 294, F928–F936.
Baxter, J. D., Samnaliev, M., & Clark, R. E. (2009). The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatric Services, 60, 43–49.
Bernstein, H. G., Müller, S., Steiner, J., Farkas, N., Bogerts, B., & Lendeckel, U. (2010). Association between paternal schizophrenia and low birthweight: ADAM12 may matter. Asian Journal of Andrology, 12, 453–454.
Bespalova, I. N., Angelo, G. W., Smith, C. J., Durner, M., Siever, L. J., Carrion-Baralt, J., et al. (2005). Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family. Psychiatric Genetics, 15, 205–210.
Bespalova, I. N., Durner, M., Ritter, B. P., Angelo, G. W., Rossy-Fullana, E., Carrion-Baralt, J., et al. (2010). Non-synonymous variants in the AMACR gene area associated with schizophrenia. Schizophrenia Research, 124, 208–215.
Biliya, S., & Bulla, L. A., Jr. (2010). Genomic imprinting: the influence of differential methylation in the two sexes. Experimental Biology and Medicine (Maywood), 235, 139–147.
Bondeson, J., Wainwright, S., Hughes, C., & Caterson, B. (2008). The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: A review. Clinical and Experimental Rheumatology, 26, 139–145.
Boustany, R. M., Qian, W. H., & Suzuki, K. (1993). Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients. American Journal of Human Genetics, 53, 881–888.
Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010). Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. Schizophrenia Research, 117, 75–82.
Bressan, F. F., De Bem, T. H., Perecin, F., Lopes, F. L., Ambrosio, C. E., Meirelles, F. V., et al. (2009). Unearthing the roles of imprinted genes in the placenta. Placenta, 30, 823–834.
Brown, S., Inskip, H., & Barraclough, B. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212–217.
Cal, S., Arguelles, J. M., Fernandez, P. L., & López-Otín, C. (2001). Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. Journal of Biological Chemistry, 276, 17932–17940.
Capasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & St. Sauver, J. (2008). Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005. Schizophrenia Research, 98, 287–294.
Chang, H. R., Yang, S. F., Li, M. L., Lin, C. C., Hsieh, Y. S., & Lian, J. D. (2006). Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease. Clinica Chimica Acta, 366, 243–248.
Chen, Y. H., Lee, H. C., & Lin, H. C. (2009). Prevalence and risk of atopic disorders among schizophrenia patients: A nationwide population based study. Schizophrenia Research, 108, 191–196.
Chissoe, S., Ehm, M. G., & St. Jean, P. (2008). Genes associated with schizophrenia. United States Patent Application 20080176239, 42.
Choke, E., Cockerill, G., Wilson, W. R., Sayed, S., Dawson, J., Loftus, I., et al. (2005). A review of biological factors implicated in abdominal aortic aneurysm rupture. European Journal of Vascular and Endovascular Surgery, 30, 227–244.
Cooper-Casey, K., Mesen-Fainardi, A., Galke-Rollins, B., Llach, M., Laprade, B., Rodriguez, C., et al. (2005). Suggestive linkage of schizophrenia to 5p13 in Costa Rica. Molecular Psychiatry, 10, 651–656.
Crowe, R. R., & Vieland, V. (1999). Report of the chromosome 5 workshop of the sixth world congress on psychiatric genetics. American Journal of Medical Genetics, 88, 229–232.
Dehmel, T., Janke, A., Hartung, H. P., Goebel, H. H., Wiendl, H., & Kieseier, B. C. (2007). The cell-specific expression of metalloproteinase-disintegrins (ADAM) in inflammatory myopathies. Neurobiology of Disease, 25, 665–674.
Dow, D. J., Huxley-Jones, J., Hall, J. M., Francks, C., Maycox, P. R., Kew, J. N., et al. (2011). ADAMTSL3 as a candidate gene for schizophrenia: Gene sequencing and ultra-high density association analysis by imputation. Schizophrenia Research, 127, 28–34.
El Hour, M., Moncada-Pazos, A., Blacher, S., Masset, A., Cal, S., Berndt, S., et al. (2010). Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene, 29, 3025–3032.
Elkington, P. T., Nuttall, R. K., Boyle, J. J., O’Kane, C. M., Horncastle, D. E., Edwards, D. R., et al. (2005). Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. American Journal of Respiratory and Critical Care Medicine, 172, 1596–1604.
Farkas, N., Lendeckel, U., Dobrowolny, H., Funke, S., Steiner, J., Keilhoff, G., et al. (2010). Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry, 11, 556–566.
Feldman, J. M., Ortega, A. N., McQuaid, E. L., & Canino, G. (2006). Comorbidity between asthma attacks and internalizing disorders among Puerto Rican children at one-year follow-up. Psychosomatics, 47, 333–339.
Fujishima, S., Shiomi, T., Yamashita, S., Yogo, Y., Nakano, Y., Inoue, T., et al. (2010). Production and activation of matrix metalloproteinase 7 (Matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis. Archives of Pathology and Laboratory Medicine, 134, 1136–1142.
Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., et al. (2002). The structure of haplotype blocks in the human genome. Science, 296, 2225–2229.
Goldacre, M. J., Kurina, L. M., Wotton, C. J., Yeates, D., & Seagroat, V. (2005). Schizophrenia and cancer: an epidemiological study. British Journal of Psychiatry, 187, 334–338.
Greenwood, T. A., Lazzeroni, L. C., Murray, S. S., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., et al. (2011). Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the consortium on the genetics of schizophrenia. American Journal of Psychiatry, Apr 15 [Epub ahead of print].
Gueders, M. M., Foidart, J. M., Noel, A., & Cataldo, D. D. (2006). Matrix metalloproteinases (MMP) and tissue inhibitors of MMP in the respiratory tract: Potential implications in asthma and other lung diseases. European Journal of Pharmacology, 533, 133–144.
Haeusler, G., Walter, I., Helmreich, M., & Egerbacher, M. (2005). Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcified Tissue International, 76, 326–335.
Hall, N. G., Klenotoic, P., Anand-Apte, B., & Apte, S. S. (2003). ADAMTSL-3/punctin-2, a novel glycoprotein in extracellular matrix related to the ADAMTS family of metalloproteases. Matrix Biology, 22, 501–510.
Hattori, E., Toyota, T., Ishitsuka, Y., Iwayama, Y., Yamada, K., Ujike, H., et al. (2009). Preliminary genome-wide association study of bipolar disorder in the Japanese population. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 150B, 1110–1117.
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., et al. (2009). Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences USA, 106, 9362–9367.
Holliday, E. G., Mowry, B. J., & Nyholt, D. R. (2008). A reanalysis of 409 European-Ancestry and African American schizophrenia pedigrees reveals significant linkage to 8p23.3 with evidence of locus heterogeneity. American Journal of Medical Genetics B. Neuropsychiatric Genetics, 147B, 1080–1088.
Hu, P. Y., Ernst, A. R., Sly, W. S., Venta, P. J., Skaggs, L. A., & Tashian, R. E. (1994). Carbonic anhydrase II deficiency: Single-base deletion in exon 7 is the predominant mutation in Caribbean Hispanic patients. American Journal of Human Genetics, 54, 602–608.
Johnson, A. D., & O’Donnell, C. J. (2009). An open access database of genome-wide association results. BMC Medical Genetics, 10, 6.
Jones, D. R., Macias, C., Barreira, P. J., Fisher, W. H., Hargreaves, W. A., & Harding, C. M. (2004). Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatric Services, 55, 1250–1257.
Jones, G. C., & Riley, G. P. (2005). ADAMTS proteinases: A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Research and Therapy, 7, 160–169.
Karayiorgou, M., & Gogos, J. A. (2006). Schizophrenia genetics: Uncovering positional candidate genes. European Journal of Human Genetics, 14, 512–519.
Kevorkian, L., Young, D. A., Darrah, C., Donell, S. T., Shepstone, L., Porter, S., et al. (2004). Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis and Rheumatism, 50, 131–141.
Koike, A., Nishida, N., Inoue, I., Tsuji, S., & Tokunaga, K. (2009). Genome-wide association database developed in the Japanese Integrated Database Project. Journal of Human Genetics, 54, 543–546.
Kurz, T., Hoffjan, S., Hayes, M. G., Schneider, D., Nicolae, R., Heinzmann, A., et al. (2006). Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. Journal of Allergy and Clinical Immunology, 118, 396–402.
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007). Physical illness and schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica, 116, 317–333.
Levy, G. G., Nichols, W. C., Lian, E. C., Foroud, T., McClintick, J. N., McGee, B. M., et al. (2001). Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488–494.
Libby, P., Aikawa, M., & Jain, M. K. (2006). Vascular endothelium and atherosclerosis. Handbook of Experimental Pharmacology, 176, 285–306.
Lin, H. C., Tang, C. H., & Lee, H. C. (2009). Association between paternal schizophrenia and low birthweight: A nationwide populationbased study. Schizophrenia Bulletin, 35, 624–639.
Liu, C. J. (2009). The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. Nature Clinical Practice Rheumatology, 5, 38–45.
Liu, C. J., Kong, W., Xu, K., Luan, Y., Ilalov, K., Sehgal, B., et al. (2006). ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. Journal of Biological Chemistry, 281, 15800–15808.
Llamazares, M., Obaya, A. J., Moncada-Pazos, A., Heljasvaara, R., Espada, J., López-Otín, C., et al. (2007). The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. Journal of Cell Science, 120, 3544–3552.
Lopez-Otin, C., & Matrisian, L. M. (2007). Emerging roles of proteases in tumour suppression. Nature Reviews Cancer, 7, 800–808.
Malemud, C. J. (2006). Matrix metalloproteinases (MMPs) in health and disease: An overview. Frontiers in Bioscience, 11, 1696–1701.
Mandal, M., Mandal, A., Das, S., Chakraborti, T., & Sajal, C. (2003). Clinical implications of matrix metalloproteinases. Molecular and Cellular Biochemistry, 252, 305–329.
Marion, R. W., Chitayat, D., Hutcheon, R. G., Goldberg, R., Shprintzen, R. J., & Cohen, M. M. (1987). Autosomal recessive inheritance in the Setleis bitemporal ‘forceps marks’ syndrome. American Journal of Diseases of Children, 141, 895–897.
Miozzo, M., & Simoni, G. (2002). The role of imprinted genes in fetal growth. Biology of the Neonate, 81, 217–228.
Moncada-Pazos, A., Obaya, A. J., Fraga, M. F., Viloria, C. G., Capellá, G., Gausachs, M., et al. (2009). The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. Journal of Cell Science, 122, 2906–2913.
Morales, C. A. (1983). Puerto Rico: A political and cultural history. New York: W.W. Norton.
Morrison, A. C., Felix, J. F., Cupples, L. A., Glazer, N. L., Loehr, L. R., Dehghan, A., et al. (2010). Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circulation: Cardiovascular Genetics, 3, 248–255.
Murphy, G. (2008). The ADAM: Signalling scissors in the tumour microenvironment. Nature Reviews Cancer, 8, 929–941.
Murphy, G., & Nagase, H. (2008). Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: Destruction or repair? Nature Clinical Practice Rheumatology, 4, 128–135.
Need, A. C., Ge, D., Weale, M. E., Maia, J., Feng, S., Heinzen, E. L., et al. (2009). A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genetics, 5, e1000373.
Oetting, W. S., Witkop, C. J., Jr., Brown, S. A., Colomer, R., Fryer, J. P., Bloom, K. E., et al. (1993). A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. American Journal of Human Genetics, 52, 17–23.
Okada, Y. (2009). Proteinases and matrix degradation. In G. S. Firestein, R. C. Budd, E. D. Harris Jr., I. B. McInnes, S. Ruddy, & J. S. Sergent (Eds.), Kelly’s textbook of rheumatology (8th ed., pp. 115–134). Philadelphia, PA: Saunders Elsevier.
Ortega, N., Behonick, D., Stickens, D., & Werb, Z. (2003). How proteases regulate bone morphogenesis. Annals of the New York Academy of Science, 995, 109–116.
Ortega, A. N., Goodwin, R. D., McQuaid, E. L., & Canino, G. (2004). Parental mental health, childhood psychiatric disorders, and asthma attacks in island Puerto Rican youth. Ambulatory Pediatrics, 4, 308–315.
Paunio, T., Ekelund, J., Varilo, T., Parker, A., Hovatta, I., Turunen, J. A., et al. (2001). Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Human Molecilar Genetics, 10, 3037–3048.
Pearce, W. H., & Shively, V. P. (2006). Abdominal aortic aneurysm as a complex multifactorial disease: Interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Annals of the New York Academy of Sciences, 1085, 117–132.
Porter, S., Clark, I. M., Kevorkian, L., & Edwards, D. R. (2005). The ADAMTS metalloproteinases. Biochemical Journal, 386, 15–27.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., et al. (2007). PLINK: A toolset for whole-genome association and population-based linkage analysis. American Journal of Human Genetics, 81, 559–575.
Rampersaud, E., Damcott, C. M., Fu, M., Shen, H., McArdle, P., Shi, X., et al. (2007). Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: Evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes, 56, 3053–3062.
Renn, J. H., Yang, N. P., Chueh, C. M., Lin, C. Y., Lan, T. H., & Chou, P. (2009). Bone mass in schizophrenia and normal populations across different decades of life. BMC Musculosceletal Disorders, 10, 1–7.
Rocks, N., Paulissen, G., El Hour, M., Quesada, F., Crahay, C., Gueders, M., et al. (2008). Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie, 90, 369–379.
Romeo, M. G., Distefano, G., Di Bella, D., Mangiagli, A., Caltabiano, L., Roccaro, S., et al. (1991). Familial Jarcho-Levin syndrome. Clinical Genetics, 39, 253–259.
Rosenberg, G. A. (2009a). Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurology, 8, 205–216.
Rosenberg, G. A. (2009b). Matrix metalloproteinases in neuroinflammation. Glia, 39, 279–291.
Rybakowski, J. K., Skibinska, M., Kapelski, P., Kaczmarek, L., & Hauser, J. (2009). Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophrenia Research, 109, 90–93.
Sadler, J. E. (2008). Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 112, 11–18.
Salter, R. C., Ashlin, T. G., Kwan, A. P., & Ramji, D. P. (2010). ADAMTS proteases: Key roles in atherosclerosis? Journal of Molecular Medicine, 88, 1203–1211.
Schwettmann, L., Wehmeier, M., Jokovic, D., Aleksandrova, K., Brand, K., Manns, M. P., et al. (2008). Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. Journal of Hepatology, 49, 243–250.
Shindo, T., Kurihara, H., Kuno, K., Yokoyama, H., Wada, T., Kurihara, Y., et al. (2010). ADAMTS-1: A metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. Journal of Clinical Investigation, 105, 1345–1352.
Shiomi, T., Lemaître, V., D’Armiento, J., & Okada, Y. (2010). Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathology International, 60, 477–496.
Silverman, J. M., Greenberg, D. A., Altstiel, L. D., Siever, L. J., Mohs, R. C., Smith, C. J., et al. (1996). Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. American Journal of Medical Genetics, 67, 162–171.
Smith, R. L. (1999). Degradative enzymes in osteoarthritis. Frontiers in Bioscience, 4, D704–D712.
Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., et al. (2004). Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. Journal of Nervous and Mental Disease, 192, 421–427.
Spinale, F. G. (2007). Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiological Reviews, 87, 1285–1342.
Suarez, B. K., Duan, J., Sanders, A. R., Hinrichs, A. L., Jin, C. H., Hou, C., et al. (2006). Genomewide Linkage Scan of 409 European-Ancestry and African American Families with Schizophrenia: Suggestive Evidence of Linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the Combined Sample. American Journal of Human Genetics, 78, 315–333.
Tang, B. L. (2001). ADAMTS: a novel family of extracellular matrix proteases. International Journal of Biochemistry and Cell Biology, 33, 33–44.
Tiwari, A. K., Zai, C. C., Müller, D. J., & Kennedy, J. L. (2010). Genetics in schizophrenia: where are we and what next? Dialogues in Clinical Neurosciences, 12, 289–303.
Torrey, E. F. (2006). Prostate cancer and schizophrenia. Adult Urology, 68, 1280–1283.
Tortorella, M. D., & Malfait, A. M. (2008). Will the real aggrecanase(s) step up: Evaluating the criteria that define aggrecanase activity in osteoarthritis. Current Pharmaceutical Biotechnology, 9, 16–23.
Vázquez, F., Hastings, G., Ortega, M. A., Lane, T. F., Oikemus, S., Lombardo, M., et al. (1999). METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. Journal of Biological Chemistry, 274, 23349–23357.
Witkop, C. J., Almadovar, C., Pineiro, B., & Nunez Babcock, M. (1990). Hermansky–Pudlak syndrome (HPS). An epidemiologic study. Ophthalmic Paediatric Genetics, 11, 245–250.
Wu, Z. S., Wu, Q., Yang, J. H., Wang, H. Q., Ding, X. D., Yang, F., et al. (2008). Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. International Journal of Cancer, 122, 2050–2056.
Yang, P., Baker, K. A., & Hagg, T. (2006). The ADAMs family: Coordinators of nervous system development, plasticity and repair. Progress in Neurobiology, 79, 73–94.
Yong, V. W. (2005). Metalloproteinases: mediators of pathology and regeneration in the CNS. Nature Reviews Neuroscience, 6, 931–944.
Zeng, W., Corcoran, C., Collins-Racie, L. A., Lavallie, E. R., Morris, E. A., & Flannery, C. R. (2006). Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTS: Comparative analyses with ADAMTS-5, -9, -16 and -18. Biochimica and Biophysica Acta, 1760, 517–524.
Acknowledgments
The authors thank patients and healthy volunteers for their participation in the study. We also thank Enrique Rossy-Fullana and Jose Carrión-Baralt for samples collection and administrative assistance. We thank Martina Durner and James Schmeidler for helpful discussions and Inga Peter for assistance with logistic regression analysis. We are grateful to Andrei Kurochkin and anonymous reviewers for critical reading of the manuscript and useful comments and suggestions. The study was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) to INB (Young Investigator Award), the National Institute of Mental Health (NIMH) to INB (RO3 Award MH082134), and The Department of Veterans Affairs (VA) to JMS (Merit Award). The funding sources had no role in study design, analysis and interpretation of the data, and writing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bespalova, I.N., Angelo, G.W., Ritter, B.P. et al. Genetic Variations in the ADAMTS12 Gene are Associated with Schizophrenia in Puerto Rican Patients of Spanish Descent. Neuromol Med 14, 53–64 (2012). https://doi.org/10.1007/s12017-012-8169-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-012-8169-y